Search - tctmd.com

Displaying 441 - 460 of 806

Sort: Relevancy | Date

Presentation TCT 2015

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

Presenter: Sigmund Silber, Philip M. Urban, David E. Kandzari

October 13, 2015

Presentation TCT 2015

TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention

Presenter: Sigmund Silber, Philip M. Urban, Philippe Généreux

October 13, 2015

Presentation TCT 2015

TCT 6: Five-Year Optical Coherence Tomography of Patients With ST-Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents (the RE-EXAMINATION Study)

Presenter: Eric Boersma, Richard Smalling, Josep Gomez Lara

October 13, 2015

Presentation TCT 2015

TCT 15: Multislice Computed Tomography Assessment of Absorb Bioresorbable Vascular Scaffold in Comparison With Metallic Drug-Eluting Stents Data From the ABSORB Japan Trial

Presenter: Stephen G. Ellis, Lorenz Raber, Kengo Tanabe

October 13, 2015

Presentation TCT 2015

TCT 63: One-Year Results of the REMEDEE Registry Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered Stent in a Multicenter, Prospective Postmarket Registry

Presenter: Sigmund Silber, Philip M. Urban, Robert de Winter

October 13, 2015

Presentation TCT 2015

TCT 47: Comparative Optical Coherent Tomographic Analysis of In-Stent Neoatherosclerosis Between First- and Second-Generation Drug-Eluting Stents

Presenter: Stephan Achenbach, Marc D. Feldman, Mineok Chang

October 13, 2015

Presentation TCT 2015

TCT 62: Predicting Value of Platelet Reactivity on Bleeding and Major Adverse Cardiac Events in Eastern Asian Percutaneous Coronary Intervention Patients

Presenter: Sigmund Silber, Philip M. Urban, Wenyao Wang

October 13, 2015

Presentation TCT 2015

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions Insights From the I-LOVE-IT 2 Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Bo Xu

October 13, 2015

Presentation TCT 2015

TCT 19: Two-Year Clinical Outcomes and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Nonbifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

Presenter: Eric A. Cohen, Truls Råmunddal, Liefke van der Heijden

October 13, 2015

Presentation TCT 2015

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

Presenter: Sigmund Silber, Philip M. Urban, Evgeny Kretov

October 13, 2015

Presentation TCT 2015

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Presenter: Sigmund Silber, Philip M. Urban, Sorin J. Brener

October 13, 2015

Presentation TCT 2015

Case 8: Small Vessels - The Svelte Stent

Presenter: Martin B. Leon, Pieter C. Smits, Pieter R. Stella

October 12, 2015

Presentation TCT 2015

Case 7: Very Long Lesions in Tapering Vessels - The BioMime Morph Stent

Presenter: Martin B. Leon, Pieter C. Smits, Teguh Santoso

October 12, 2015

Presentation TCT 2015

Case 6: Acute Myocardial Infarction or Thrombus Containing Lesions - The MGuard Prime Stent

Presenter: Martin B. Leon, Pieter C. Smits, Chaim S. Lotan

October 12, 2015

Presentation TCT 2015

Case 5: Bifurcations or Left Main - The Tryton Stent

Presenter: Martin B. Leon, Pieter C. Smits, Robert-Jan van Geuns

October 12, 2015

Presentation TCT 2015

Case 4:Bifurcations or Left Main - The Stentys Stent

Presenter: Martin B. Leon, Pieter C. Smits, Carlo Briguori

October 12, 2015

Presentation TCT 2015

Case 3: Bifurcations or Left Main - The Nile Stent

Presenter: Martin B. Leon, Pieter C. Smits, Ivo Petrov

October 12, 2015

Presentation TCT 2015

Case 2: Bifurcations or Left Main - The BiOSS Stent

Presenter: Martin B. Leon, Pieter C. Smits, Robert J. Gil

October 12, 2015

Presentation TCT 2015

Case 1: Bifurcations or Left Main - The Axxess Stent

Presenter: Martin B. Leon, Pieter C. Smits, Christophe Dubois

October 12, 2015

Presentation TCT 2015

Cre8: Design, Current Status, and Future Directions

Presenter: Marie-Claude Morice, Leif Thuesen, Didier Carrié

October 12, 2015

Advertisement

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention

TCT 6: Five-Year Optical Coherence Tomography of Patients With ST-Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents (the RE-EXAMINATION Study)

TCT 15: Multislice Computed Tomography Assessment of Absorb Bioresorbable Vascular Scaffold in Comparison With Metallic Drug-Eluting Stents Data From the ABSORB Japan Trial

TCT 63: One-Year Results of the REMEDEE Registry Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered Stent in a Multicenter, Prospective Postmarket Registry

TCT 47: Comparative Optical Coherent Tomographic Analysis of In-Stent Neoatherosclerosis Between First- and Second-Generation Drug-Eluting Stents

TCT 62: Predicting Value of Platelet Reactivity on Bleeding and Major Adverse Cardiac Events in Eastern Asian Percutaneous Coronary Intervention Patients

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions Insights From the I-LOVE-IT 2 Trial

TCT 19: Two-Year Clinical Outcomes and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Nonbifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Case 8: Small Vessels - The Svelte Stent

Case 7: Very Long Lesions in Tapering Vessels - The BioMime Morph Stent

Case 6: Acute Myocardial Infarction or Thrombus Containing Lesions - The MGuard Prime Stent

Case 5: Bifurcations or Left Main - The Tryton Stent

Case 4:Bifurcations or Left Main - The Stentys Stent

Case 3: Bifurcations or Left Main - The Nile Stent

Case 2: Bifurcations or Left Main - The BiOSS Stent

Case 1: Bifurcations or Left Main - The Axxess Stent

Cre8: Design, Current Status, and Future Directions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content